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PHOTOPLETHYSMOGRAPHIC WAVEFORM ANALYSIS DURING 
LOWER BODY NEGATIVE PRESSURE SIMULATED HYPOVOLEMIA 
AS A TOOL TO DISTINGUISH REGIONAL DIFFERENCES IN 
MICROVASCULAR BLOOD FLOW REGULATION. 
 
Nicholas J. Galante, Lars J. Grimm, Aymen A. Alian, Nina S. Stachenfeld, Kirk H. 
Shelley, and David G. Silverman, Department of Anesthesiology, Yale University, 
School of Medicine, New Haven, CT  
 
The purpose of this investigation was to explore modulation of the 
photoplethsymographic (PPG) waveform in the setting of simulated hypovolemia 
as a tool to distinguish regional differences in regulation of the microvasculature. 
The primary goal was to glean useful physiological and clinical information as it 
pertains to these regional differences in regulation of microvascular blood flow. 
This entailed examining the cardiovascular, autonomic nervous, and respiratory 
systems’ interplay in the functional hemodynamics of regulation of microvascular 
blood flow to both central (ear, forehead) and peripheral (finger) sites. 
 
We monitored ten healthy volunteers (both men and women age 24-37 ) non-
invasively with central and peripheral photoplethysmographs and laser Doppler 
flowmeters during Lower Body Negative Pressure (LBNP). Waveform amplitude, 
width, and oscillatory changes were characterized using waveform analysis 
software (Chart, ADInstruments). Data were analyzed with the Wilcoxon Signed 
Ranks Test, paired t-tests, and linear regression.  
 
Finger PPG amplitude decreased by 34.6 ± 17.6% (p = 0.009) between baseline 
and the highest tolerated LBNP. In contrast, forehead amplitude changed by only 
2.4 ± 16.0% (p=NS). Forehead and finger PPG width decreased by 48.4% and 
32.7%, respectively. Linear regression analysis of the forehead and finger PPG 
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waveform widths as functions of time generated slopes of -1.113 (R = -0.727) and 
-0.591 (R = -0.666), respectively. A 150% increase in amplitude density of the ear 
PPG waveform was noted within the range encompassing the respiratory 
frequency (0.19-0.3Hz) (p=0.021) attributable to changes in stroke volume. We 
also noted autonomic modulation of the ear PPG signal in a different frequency 
band (0.12 – 0.18 Hz). 
 
The data indicate that during a hypovolemic challenge, healthy volunteers had a 
relative sparing of central cutaneous blood flow when compared to a peripheral 
site as indicated by observable and quantifiable changes in the PPG waveform. 
These results are the first documentation of a local vasodilatation at the level of 
the terminal arterioles of the forehead that may be attributable to recently 
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The photoelectric plethysmograph (PPG) was first described over seventy years 
ago1-3. Since that time, the PPG waveform has been studied and used clinically for 
a multitude of purposes.  The discovery of its utility in the calculation of arterial 
oxygen saturation in the mid 1970’s, however, had such a profound impact on 
clinical monitoring that the other potential uses of the waveform quickly faded 
from the attention of clinicians. Further neglect came from the waveform’s 
absence from early stand-alone pulse oximeters, where the pulse was indicated by 
either a bouncing bar or flashing heart symbol.4  
 
The pulse oximeter, as a photoelectric plethysmograph, non-invasively measures 
minute changes in blood volume of a vascular bed (e.g finger, ear, or forehead) 
over time. In this capacity, it has the ability to monitor differences between those 
microvascular beds with respect to blood flow.  Regional differences exist in the 
regulation of blood flow in the microvasculature.  Specifically, sympathetic 
activation, such as cold pressor testing and use of pharmacological agents (i.e. 
phenylephrine), cause disproportionate vasoconstriction of an adrenergically rich 
region such as the finger, as opposed to the ear or forehead, which have less 
adrenergic innervation 5-7.  
 
Where previous investigation of the PPG has focused on its potential as an 
anesthesia monitoring device8, over the course of its history, remarkably little has 
been done in the way of studying the device’s ability to measure the 
aforementioned regional terminal arteriolar and microvascular differences4. This 
thesis will explore modulation of the PPG waveform in the setting of simulated 
hypovolemia. The primary aim of this investigation was to glean useful 
physiological and clinical information as it pertains to regional differences in 
regulation of microvascular blood flow.  To this end, we examined the 
cardiovascular, autonomic nervous, and respiratory systems’ interplay in the 
functional hemodynamics of regulation of microvascular blood flow to both 
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central (ear, forehead) and peripheral (finger) sites. The underlying hypothesis is 
that the PPG waveform can be used to detect, elucidate, and characterize these 
differences, as well as offer plausible explanations for these differing vascular 
responses to hypovolemia.   
 
SOURCE OF THE WAVEFORM  
 
The term “plethysmograph” is derived from the Greek root “plethysmos” meaning 
“to increase.” Photoplethysmography, in simplest terms, is an optical 
measurement technique that can be used to detect blood volume changes in a 
microvascular bed in the tissue. There is a close correlation (r = 0.9) between the 
PPG and the more traditional strain gauge plethysmograph9.  
 
The elements that contribute to the pulse oximeter waveform are described by 
Beer’s law of light:  
 
Atotal = E1C1L1 + E2C2L2 + …EnCnLn 
 
Where,  
Atotal = absorption at a given wavelength  
En   = extinction coefficient (absorbency)  
Cn   = concentration  
Ln   = path length  
 
The PPG itself is a simple device. It consists of a light source (most commonly an 
LED) and light detector (photo diode). The detector can be placed either directly 
across from the light source for transmission plethysmography or next to the light 







Figure 1. A transmission PPG consisting of a light source (most commonly an LED), light 
detector (photo diode), and tissue to be studied (path). 
 
Conceptually, the pulse oximeter waveform is most easily viewed as measuring 
the change in blood volume (more specifically path length), during a cardiac 
cycle, in the region being studied (typically the fingertip or earlobe). The general 
consensus is that the waveform comes from the site of maximum pulsation within 
the arteriolar vessels where pulsatile energy is converted to smooth flow just 
before the level of the capillaries9, 10.  
 
The pulsatile component of the PPG waveform is often called the AC component 
and has a fundamental frequency typically around 1 Hz, depending on heart rate 
(Figure 2). This AC component is superimposed onto a large DC component that 
relates to the average tissue blood volume.11 The DC component varies slowly due 
to respiration, vasomotor activity and vasoconstrictor waves, Traube Hering 





Figure 2. The pulsatile (AC) component of the PPG signal and corresponding electrocardiogram 
(ECG). The AC component is actually superimposed on a much larger DC component that 
relates to the tissues and to the average blood volume within the sample. It represents the increased 
light attenuation associated with the increase in terminal arteriolar blood volume with each 
heartbeat.11 
 
In researching the PPG waveform, it is paramount to appreciate the fact that the 
waveform displayed on commercial pulse oximeters is a highly processed and 
filtered signal.  Normally, equipment manufacturers use both auto-centering and 
auto-gain routines on the displayed PPG waveforms, as well as implement both 




Figure 3. The signal conditioning stages surrounding the transimpedance amplifier which include 
low pass filtering, high pass filtering and further amplification, inversion and signal interfaces.11 
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Typically, there are two wavelengths measured by the pulse oximeter: 940 nm 
and 660 nm. Traditionally only the infrared signal (940 nm) is presented, because 
it is more stable over time, especially when compared to the red signal (660 nm), 
which is more susceptible to changes in the oxygen saturation.4 In addition, only 
the pulsatile component or AC portion is displayed. The DC component is 
eliminated by an auto centering routine used to ensure the waveform remains on 
the display screen.4 With changes in the degree of venous congestion, the 
waveform can be noted to drift partly off the screen and then return via the auto-
centering algorithm. The auto-gain function is designed to maximize the size of 
the waveform displayed.23 However, with its use, it becomes impossible to 




Despite the esthetic processing, the PPG waveform is still rich in information 
regarding the physiology of the patient. It contains a complex mixture of the 
influences of arterial, venous, autonomic, and respiratory systems on the central 
and peripheral circulation. When using clinical monitoring devices as research 
devices, one must learn how to cope with proprietary filters and algorithms, so as 
to extract underlying signals that contribute to the complex waveform and to 
study how these underlying signals vary over time24. Key to the successful 
interpretation of this waveform is the ability to separate it into fundamental 




When examining the PPG waveform, taking note of the region of the body being 
measured is important. By their nature, pulse oximeters are pulse-dependent, and 
a site with adequate perfusion is required. Thus the performance of sensors placed 
on the extremities can be impaired by multiple conditions such as low perfusion25, 
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26 and motion artifact27. One solution to this problem is the placement of sensors 
on the head (e.g. ear, forehead, lip, and nose)28. This, of course, creates other 
issues such as challenges with method of attachment and potential reduction of 
signal strength. 
 
In the finger, where the walls of the cutaneous vessels are richly innervated by 
alpha-adrenoceptors, the sensitivity to changes in the sympathetic nervous system 
are greater than when compared to other areas of the body such as the earlobe23. 
Thus, a technique such as plethysmography may be more influenced by changes 
in adrenergic tone at the finger than at other sites. This has prompted clinicians to 
explore the usefulness of plethysmographic signals at other sites as a means of 
minimizing the effect of local vasoconstriction on the measurements of oxygen 
saturation and assessments of waveform morphology7,28. 
 
During a cold immersion test, which is a classic method of eliciting a 
vasoconstrictive reflex by immersing a hand in ice water (4 ◦ C), it has been 
shown that the amplitude of the ear PPG was relatively immune to 
vasoconstrictive effect while the contralateral finger PPG waveform showed 
marked reduction in amplitude. This underscores an important idea in site specific 
PPG waveform analysis: the ear tracing may reflect central hemodynamic changes 
while the finger pulse oximeter waveform might be used as a monitor of 
sympathetic tone and peripheral vascular events23.  
 
Additional support for differing regulation of the central and peripheral 
microcirculation comes from an investigation showing contrasting responses, as 
measured by laser Doppler flowmetry, in forehead and finger microvascular flow 
in response to systemic administration of phenylephrine, a vasoconstrictive drug.  
This was accompanied by an induced oscillatory response that was detectable in 
the forehead microvasculature by measuring red cell flux with laser Doppler 
flowmetry. The oscillations occurred at a “high” frequency (0.18 Hz), which was 
consistent with mediation via parasympathetic pathways.29-33 The cholinergic 
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etiology of these high frequency oscillations was confirmed by their elimination 
by systemic administration of atropine.34   
 
Prior analysis of the PPG waveform during hypovolemia has shown that it can be 
modulated by positive pressure ventilation similar to ventilation induced variation 
of systolic blood pressure35-37. Furthermore, following the withdrawal of 450 ml of 
blood in healthy volunteers, there was a significant increase in the respiratory 
induced oscillation of the ear PPG tracing during spontaneous and continuous 
positive airway pressure ventilation despite the absence of changes in heart rate or 
blood pressure38 In addition, prior work by members of our group has 
demonstrated the respiratory signal when measured in the ear PPG waveform is 
10 times stronger compared to the finger PPG 39. 
 
            AMPLITUDE ANALYSIS  
 
Plethysmographic analysis has typically focused on the amplitude of the 
waveform (Figure 5). Amplitude changes can be concealed by the auto-gain 
function found on most pulse oximeters. By turning off the auto-gain, certain 
observations can be made. For example, over a remarkably wide range of cardiac 
output, the amplitude of the PPG signal is directly proportional to stroke volume 
and local vascular distensibility8. With a decrease in stroke volume, a smaller 
volume of blood is delivered to the circulation with each cardiac cycle.  This will 
result in decreased waveform amplitude, and vice versa. Additionally, if the 
vascular compliance is low, as in episodes of increased sympathetic tone, the 
pulse oximeter waveform amplitude is also low; in contrast, during vasodilatation, 
the pulse oximeter waveform amplitude is increased. It is important to realize that 
a large pulse amplitude does not imply the presence of high arterial blood 
pressure nor vice versa.4 The pulse oximeter waveform amplitude decreases 
during significant increases in arterial blood pressure due to increased 
sympathetic tone. For example, during surgical incision there is normally a 
profound decrease in the amplitude of the finger PPG when compared to the ear 
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pinna (Figure 4). This observation has been interpreted as being directly related to 




Figure 4. Effect of surgical incision on a subject under general anesthesia on the 
photoplethysmograph (PPG) and blood pressure (BP). With an increase in sympathetic tone, SVR 
increases as does BP, where as PPG amplitude decreases as a result of decreased vascular 
compliance seen with vasoconstriction.40 
 
Once a baseline measurement has been established, the pulse oximeter amplitude 
can be followed as a gauge of sympathetic tone and systemic vascular resistance41-
43. A potential use for such monitoring is in changes in arterial blood pressure, 
particularly hypotension, in critically ill patients. Hypotension is a late feature of 
circulatory collapse because compensatory measures, including changes in 
systemic vascular resistance (SVR), often mask hemorrhage and other forms of 
volume loss. The ability to continuously measure SVR and flow allows for early 
detection of active compensatory mechanisms, thereby enabling early detection of 
volume loss and characterization of the nature of the shock.4 However, continuous 
monitoring of SVR requires use of invasive techniques, whereas with the PPG, 





An appreciation of the changes in PPG pulse width (Figure 5) may provide 
valuable information with respect to changes in peripheral vascular tone, vessel 
caliber, blood pressure, and stroke volume.  The PPG waveform width is 
measured in seconds and represents the time through which a volume of blood 
moves through a given vascular bed. When a fluid is in motion, it must move in 





A= cross sectional area  
V= velocity 
 
This equation, when applied to the microvasculature, is not an ideal representation 
of hemodynamics. First, the equation assumes a rigid container, and does not 
account for the distensibility and variable compliance of the vascular system. 
Second, the equation assumes that there is only one pathway by which fluid can 
move, whereas there are millions of vascular beds in series and parallel in the 
terminal arterioles and microcirculation. Still, it is a useful tool for describing 
what happens to blood velocity when vessel caliber is changed. 
 
With a change in vessel diameter, blood will either change velocity, be 
redistributed to another region (parallel vascular bed), or a combination of these 
possibilities, in order to conserve energy. It is difficult to appreciate which of 
these factors predominates with vasomotor changes, due to the previously 
mentioned factors.  
 
Thus, the PPG width is a complex measurement, especially in regions such as the 
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finger, which are highly susceptible to vasomotor activity. Width is also 
dependent on heart rate, stroke volume, and PPG amplitude. A decrease in stroke 
volume whether due to hypovolemia or an increase in heart rate will cause the 
width to decrease regardless of what is happening to vessel diameter. Also, as 
width is conventionally taken at the point of half the amplitude, as amplitude 
changes so does the point at which width is measured.  
 
Despite these confounding factors, the usefulness of PPG width as a measure of 
vasculature tone and thus autonomic activity is intriguing and will be further 
investigated in this thesis. Prior research by our team has shown that the ear PPG 
pulse width correlates highly with changes in systolic blood pressure, mean blood 
pressure, and pulse pressure during open heart surgery44. Specifically, the ear 
pulse oximeter beat width was a strong predictor (r = 0.80) of blood pressure 
measured invasively from the radial artery44. Further, the ear PPG width was 
inversely related to CO and HR with correlation coefficients of (r = −0.71) and (r 
= −0.824) respectively during open-heart surgery. These findings suggest that 
with the increase in CO (either with increase HR and/or increase in contractility), 
the entire body receives more blood flow and therefore the duration of the PPG 
waveforms become shorter (reduction in the width of the pulse wave).45 
 
Additional investigation by our group with a cold pressor test, a classic method of 
eliciting a vasoconstrictive reflex by immersing a hand in ice water (4◦ C), 
demonstrated that upon hand immersion there was an increase in both systolic and 
diastolic pressures and reflexive decrease in heart rate. As a result of the increase 
in sympathetic tone, there was also a reduction of the average finger PPG width 
and a concurrent increase in ear PPG width. In proposing an explanation, we 
assumed that blood moved from an area of vasoconstriction to other sites that are 
less vasoconstricted, for example the ear or face. Thus, as a result of an increased 
blood volume load, paired with the low vascular tone of the ear blood vessels, the 
width of the ear pulse oximeter waveform increased.45 In summary, with regard to 
insight into vascular response, the PPG width can be seen as a measure of blood 
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Figure 5. Parameters studied when analyzing the photoplethsymographic waveform. 
 
 
RESPIRATORY VARIABILITY ANALYSIS  
 
Adolf Kussmaul initially described inspiration induced pulsus-paradoxus in 
187346.  Since that time the effect of respiration on the peripheral pulse has been 
described in a number of contexts.  
 
Positive pressure ventilation of an intubated patient can have a significant impact 
on both cardiac preload and afterload and, hence, stroke volume47-50. Perel and 
associates used the term ‘‘systolic pressure variation’’ to describe the impact of 
positive pressure ventilation on the arterial pressure waveform. These 
investigators concluded that the degree of systolic pressure variation as a 
consequence of the positive pressure is a sensitive indicator of hypovolemia51-53. 
Moreover, this variation is significantly more sensitive than heart rate (HR), 
systemic blood pressure (BP) and central venous pressure for identifying blood 
loss52, 53. In addition, changes in systolic pressure variation as well as pulse 
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pressure variation correspond closely to changes in pulmonary artery wedge 
pressure, left ventricular end-diastolic area, and stroke volume35, 37, 54-58.  
 
Consistent with Kussmaul’s initial report46, systolic BP variation of the arterial 
waveform also has been noted in spontaneously ventilating non-intubated 
patients. However, the effect has been less pronounced and less consistent than 
during mechanical ventilation57. .It has been hypothesized that with each positive 
pressure breath, venous return to the heart is impeded resulting in a temporary 
reduction in cardiac output 49. As a patient becomes volume depleted, with a 
resulting decrease in venous pressure, positive pressure ventilation has an 
exaggerated impact on the arterial blood pressure. Positive pressure-induced 
changes have also been detected in the PPG tracing of pulse oximeters (figure 6)8, 
36, 59-62. The ability to detect the influence of the respiratory system on the 
cardiovascular system opens many possibilities.   For example, respiratory rate 
may be reliably determined using the plethysmographic waveform63-67. 
Addionally, several groups have demonstrated that ventilation-induced waveform 
variability of the PPG signal could be used as an indicator of hypovolemia36, 69. 
 
Both the IR and red PPG traces show considerable low-frequency modulation of 
the waveform amplitude and baseline, occurring at the respiratory frequency 
(10/min [almost equal to] 0.17 Hz, Fig 6). Ventilation has two distinct effects on 
the PPG waveform: fluctuation of both the baseline (DC) and pulsatile (AC) 
components of the PPG waveform with both spontaneous and positive pressure 
ventilation.38 The most common modulation is a shift in baseline with each breath, 
which is recorded as a modulation in the DC component of the waveform (Figure 
7). Shifts in the baseline are associated with changes in the venous (i.e. 
nonpulsating) volume in the vasculature. The other phenomenon, less commonly 
seen, is variation in amplitude of the pulse beats. This AC modulation is caused 
by changes in arterial pressure induced by positive pressure ventilation and is only 





Figure 6. The effect of blood loss on the pulse oximeter waveform (Pleth) and arterial pressure 
waveform (BP). The upper diagram shows the baseline waveforms of the patient under general 
anesthesia with positive pressure ventilation. The lower diagram is after a 1000 mL blood loss. 








Figure 7. Tracings of the plethysmographs of the finger (A), ear (B), forehead (C), and peak 






Monitoring the respiratory variability seen in the pulse oximeter waveform may 
be a useful method of detecting occult hemorrhage, with its resulting 
hypovolemia70, 71. There are ongoing research efforts designed to find the best site 
and method of analysis for quantifying the effects of ventilation on the PPG 
waveform39, 72.  
 
However, since the main purpose of these devices is determination of arterial 
oxygen saturation, most oximeters have an auto-centering algorithm and a high-
pass filter, which excludes frequencies below those of cardiac pulsations – the 
goal being to facilitate visualization of the pulsatile signal rather than facilitate 
assessment of respiration-induced changes. In addition, oximeters most 
commonly are used on the finger, a region rich in sympathetic innervation that 
often reflects local (as opposed to systemic) alterations in vascular tone and 
volume status5, 8, 23, 37.  
 
In contrast to positive pressure mechanical ventilation49, spontaneous ventilation 
generates negative inspiratory pressure with transient shifting of blood from the 
peripheral vasculature to the lungs and pooling therein. This blood volume shift 
causes a decrease in peripheral venous volume as a well as a transient decrease 
(followed by an increase) in left ventricular filling. These constant shifts in central 
volume cause different effects (magnitude as well as relative timing) than positive 
pressure ventilation on venous volume in the periphery, venous flow from the 
peripheral to the pulmonary vasculature, and emptying of pulmonary beds (left 
ventricular preload) as well as on left ventricular afterload4, 38.  
 
Our colleagues have previously examined the theory that blood loss could be 
monitored through the PPG. A study was undertaken to determine the effect of the 
removal of 450 ml of blood on respiration- induced oscillations of the ear PPG 
waveform during spontaneous ventilation in healthy volunteers.38 That study 
indicated that assessment and quantification of the respiration-induced changes in 
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the ear PPG waveform has the potential of detecting volume changes in the non-
intubated patient, through quantification of respiration-induced cyclical variation 




To date little has been studied or documented regarding autonomic influences 
modulating the PPG signal. 
 
LOWER BODY NEGATIVE PRESSURE 
 
Lower body negative pressure (LBNP) will serve as our experimental model of 
hypovolemia. Application of negative pressure to the lower body redistributes 
fluid from the upper body to the lower extremities, allowing for the study of 
hemodynamic responses to central hypovolemia73-75. Since the first description of 
this research tool76, LBNP has been used by aerospace investigators to study such 
physiological phenomena as post space flight orthostatic intolerance and exposure 
to vertical acceleration in high-performance aircraft73, 75. Convertino73 investigated 
the utility and reproducibility of LBNP as a technique to study cardiovascular 
adjustments to stressors such as hemorrhage and shock and suggested that LBNP 
is a useful surrogate to study these factors in humans. Thus LBNP is an 
established model for the study of central hypovolemia73. 
 
Based on linear relationships between either hemorrhage or LBNP and central 
venous pressure or stroke volume, it appears that moderate LBNP on the order of 
10–20 mmHg is equivalent to blood loss of 400–550 ml77. Data outlining 
relationships between more severe hemorrhage and levels of LBNP are less clear, 
but suggest that LBNP between 20 and 40 mmHg corresponds to blood loss of 
between 500 and 1,000 ml, and LBNP of 40–60 mmHg corresponds to 1,000-ml 




Table 1. Classification of hemorrhage severity in humans and magnitudes of lower body negative 
pressure.77 
 
A summary of physiological response comparisons between hemorrhage and 
LBNP based on an outstanding review on the subject by Convertino and Cooke is 
shown in Table 2 and is as follows: Heart rate progressively increases with 
hemorrhage or LBNP until shock or cardiovascular collapse occurs. Collapse is 
associated with relative bradycardia at high-level LBNP and during hemorrhagic 
shock, although 60– 70% of severely bleeding patients respond with tachycardia. 
Arterial pressures are either maintained or slightly increased with progressive 
reductions of stroke volume, cardiac output, and central venous pressure, until the 
onset of shock or collapse associated with abrupt hypotension. Under both 
conditions of hemorrhage and LBNP, sympathetic neural activation is 
fundamental to the maintenance of arterial pressure, and either blunted or 
exaggerated sympathetic activation occurs before shock or collapse. However, the 
onset of hypotension occurs in conjunction with sympathetic neural withdrawal. 
Also shown in Table 2 are differential vasoactive and volume regulatory 





              Table 2. Comparison of global physiological responses to hemorrhage and LBNP.77 
 
Due to local autoregulation of various vascular beds, evaluation of 
catecholamines and other vasoactive hormones from plasma samples provides 
little insight beyond global responses into progression to cardiovascular collapse. 
The summary data presented in Table 2 show that, physiological responses to 
hemorrhage and LBNP are similar, suggesting that LBNP is a useful model to 
simulate acute hemorrhage in humans.77  
 
 
THE LASER DOPPLER FLOWMETR AS AN ADJUNCT INVESTIGATION 
TOOL 
 
Laser Doppler flowmetry is a method of non-invasive, continuous measurement 
of the microcirculation, thought to be at the level of the precapillaries and 
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capillaries. The technique is based on the values of the Doppler effect of low-
power laser light scattered randomly by static structures and moving tissue 
particulates. Like the PPG, it too is useful for measuring regional difference in 
microvascular flow as well as both sympathetic and parasympathetic influences 
on the microvasculature.34, 78 
 
Previous investigations showed a differing response in forehead and finger 
microvascular flow in response to systemic administration of phenylephrine, a 
vasoconstrictive drug.  This was accompanied by an induced oscillatory response 
that was detectable in the forehead microvasculature by measuring red cell flux 
with laser Doppler flowmetry. The oscillations occurred at a “high” frequency 
(0.12 Hz), which was consistent with mediation via parasympathetic pathways.29-
33 The cholinergic etiology of these HF oscillations was confirmed by their 
elimination by systemic administration of atropine.34  
 
In part because of its complex second-messenger system, sympathetic 
transmission to adrenergic effector sites does not elicit oscillatory responses at 
frequencies > 0.12 Hz.79 Spontaneous (myogenic) activity also tends to occur at a 
slower frequency and is less coordinated.34 Further, the elicitation of the 
oscillatory activity by phenylephrine, a known activator of a parasympathetic 
homeostatic response at the heart, and elimination of the oscillatory activity by 
atropine provided strong evidence of a parasympathetic microcirculatory 
process.34 
 
Laser Doppler flowmetry can thus provide a useful corollary to the study of the 
PPG waveform. It provides direct information about microvascular flow at a site 
just distal to that measured by the PPG. Additionally, it contains information 





PURPOSE AND HYPOTHESIS 
 
The purpose of this investigation was to explore modulation of the PPG waveform 
in the setting of simulated hypovolemia as a tool to distinguish regional 
differences in regulation of the microvasculature. To this end, we examined the 
interaction of the cardiovascular, autonomic nervous, and respiratory systems in 
regulating the functional hemodynamics of microvascular blood flow to both 
central (ear, forehead) and peripheral (finger) sites. This study can be broken 
down into two parts: time domain analysis and frequency domain analysis   
 
We first utilized time domain analysis to characterize changes in the amplitude 
and width of the PPG waveform during LBNP simulated hypovolemia. The 
underlying hypothesis is that the PPG waveform can be used to detect, elucidate, 
and characterize these differences, as well as offer plausible explanations for these 
differing vascular responses to hypovolemia. We reasoned that monitoring site- 
specific morphological differences would provide insight into the differing 
regulatory vascular response to hypovolemia: amplitude is more reflective of 
vessel compliance and caliber; width is more sensitive to blood flow transit time.  
 
In addition to these regional measurements, we also monitored capillary and pre 
capillary flow of the finger and forehead (via laser Doppler flowmetry), heart rate, 
heart rate variability, systolic, diastolic, and mean blood pressure, and an indirect 
measure of stroke volume. 
 
We also studied, through frequency domain analysis, the effect of hypovolemia 
on respiration-induced oscillations of the ear PPG waveform during spontaneous 
ventilation in healthy volunteers. We hypothesized that quantification of these 
oscillations can be used as monitor of volume status that is more sensitive than the 
classically used changes in heart rate and blood pressure. The presence of steadily 
increasing oscillations occurring at the respiratory frequency would support our 
hypothesis as well as underscore the potential of PPG as a non-invasive monitor 
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A total of 10 nonsmoking subjects (8 men and 2 women) volunteered to 
participate in this study (age, 24-37; height, 152.4 – 190.5 cm; weight, 46.4 – 90.4 
kg). Before admission into the study, all subjects underwent a brief medical 
history to ensure they had no previous or current medical conditions that might 
preclude their participation (such as cardiovascular or pulmonary disease). 
Subjects received a verbal briefing and written descriptions of all procedures and 
risks associated with the study and were made familiar with the laboratory, the 
protocol, and procedures. Subjects were encouraged to ask questions of the 
investigators, and then they signed an informed consent form approved by the 




Central hypovolemia was induced by application of LBNP to simulate, as closely 
as possible in healthy human volunteers, the hemodynamic challenges associated 
with severe hemorrhage. Subjects were positioned supine within an airtight 
chamber that was sealed at the level of the iliac crest by way of a neoprene skirt.  
Breathing frequency was regulated, with subjects breathing to a metronome set at 
a rate of 12 breathes per minute (0.2Hz). Each subject underwent exposure to 
progressive LBNP until the point of impending cardiovascular collapse. The full 
LBNP protocol consisted of 3-minute windows at baseline, -30, -60, -75, and -90 
mm Hg of chamber decompression, followed by a variable recovery period. The 
end point of the study was completion of the protocol or cardiovascular collapse 
as defined by one or a combination of the following criteria: 
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• Onset of hypovolemia associated symptoms (light headedness, nausea, 
diaphoresis).   
• Predefined change in the subject’s vital signs (a doubling of baseline heart 
rate, systolic blood pressure less than 90 mmHg with the onset of any 
symptoms, or systolic blood pressure less than 80 mmHg regardless of 
symptoms). 
• Voluntary subject termination due to discomfort.  
 
This study was performed in a climate-controlled chamber with temperature set at 
25oC and humidity set at 20%. 
 
To account for differences in LBNP tolerance between subjects, the highest level 
of negative pressure that a subject was able to tolerate, as indicated by a stability 
of vital signs and absence of symptoms, was titled “pre-symptomatic”. 
Additionally, the level of negative pressure during which a subject experienced 
symptoms was titled “symptomatic”. All other common intervals were recorded 




All subjects were monitored non-invasively. A standard 3 lead ECG was used to 
monitor heart rate and rhythm. A finger blood pressure cuff recorded continuous 
beat-by-beat finger arterial pressure (Finometer Blood Pressure Monitor, TNO-
TPD Biomedical Instrumentation, Amsterdam, The Netherlands). 
Plethysmographic monitoring was obtained with fixed-gain pulse oximeters 
(Oxypleth; Novametrix Medical Systems, Inc., Wallingford, CT) placed on the 
forehead, ear, and finger contralateral to the blood pressure cuff. Laser Doppler 
flowmetry probes (Periflux 2B; Perimed, Sweden) were applied to the skin via 
double-stick tape on the forehead and on the ventral finger contralateral to the 
blood pressure cuff. Application of a force transduction belt around the chest 
enabled breath-by-breath detection of respiratory rate and depth. Figure 8 shows 
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an image of the experimental setup. 
 
 





All waveform tracings were sampled at 200 Hz and digitized to computer with a 
microprocessor-based data acquisition system, using commercially available data 
acquisition software (PowerLab, ADInstruments). Sixty second samples of data 
from each LBNP stage were extracted for analysis.  
 
The PPG tracing was analyzed in the frequency domain using a fast Fourier 
transform (FFT) algorithm for detection and quantification of respiratory induced 
oscillations. The resulting discrete Fourier transform shows the spectrum of 
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frequencies contributing to the PPG signal, plotted as amplitude against 
frequency. The amplitude spectrum was produced using a 90 s 8192-point 
Hamming window and the zero-frequency component was removed. 
 
The PPG data from each method during each phase were analyzed with the 
spectral-domain analysis module of the Chart software (ADInstruments) using a 
Hanning window with 50% overlap based upon the formula:  
 
Gaa = [ave(SaSa*)]/df,  
 
Where in Gaa is the instantaneous amplitude spectral density of channel ‘‘a’’ (i.e., 
of the PPG waveform), Sa is instantaneous amplitude spectrum of channel ‘‘a’’, 
Sa*is complex conjugate of Sa, and df is frequency resolution. These were 
displayed with oscillatory frequency (Hz) on the x-axis and oscillatory power at 
each frequency (volt2/Hz) on the y-axis. The respiration-induced variation of the 
ear plethysmogram was quantified at the set respiratory frequency (0.2Hz). 
 
Further, time domain analysis of height and width was accomplished with the 
peak and cyclic variable analysis module of the Chart software (ADInstruments), 
respectively. Waveform amplitude was taken at the maximum height from 
baseline and width was taken as the pulse width at the 50% peak amplitude height 




All statistical analysis was done using SPSS. For the time domain analysis, data 
were compared and analyzed with paired t-tests (for vital signs and PPG 
amplitude), and linear regression analysis (for PPG width analysis).  For the 
frequency domain analysis, data were compared and analyzed using the Wilcoxon 
Signed Ranks Test (For respiratory and autonomic modulation). P-values less than 
0.05 were considered statistically significant.  P-values greater than 0.05 are 
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reported as NS. Power analysis indicated that six subjects would be required to 
detect a 50% intra-subject change in respiratory induced oscillations of the 




The level of negative pressure tolerated by each subjects was variable, and ranged 
from -40mmHg to -110mmHg of chamber decompression.  Two subjects, one 
male one female, did not experience symptoms and thus were not included in the 
final analysis as the presence of symptoms (SYMPT) was taken as an indicator of 
initial cardiovascular decompensation.  This brought the total number of subjects 
included in the study to 8. The reason for study termination for all other subjects 




Mean finger arterial blood pressure declined slowly with progressive increases in 
LBNP. The overall change in mean arterial pressure from the baseline period to 
onset of symptoms was 7.4% ± 3.8% (p < 0.05), from 99.7mmHg ± 10.3mmHg to 
90.7mmHg ± 11.8 mmHg. There was a 52.4% ± 13% (p < 0.05) decrease in mean 
pulse pressure, from 56.5mmHg ± 8.6mmHg to 25.8mmHg ± 9.8mmHg.  This 
was attributable to a 17.9% ± 4.4% (p < 0.05) decrease in mean systolic pressure 
and a 4.7% ± 2.5% (p < 0.05) increase in mean diastolic pressure. This change 
was accompanied by a 65.7% ± 26.5% (p < 0.05) progressive decrease in area of 
the pressure waveform and a progressive decrease in stroke volume based upon 





  Baseline Presympt Sympt Recovery 
SBP 138.7(9.0) 121.3(98) 113.3(10.0) 129.4(7.4) 
DBP 82.2(12.0) 84.1(11.9) 87.5(11.6) 83.4(11.1) 
PP 56.5(8.6) 37.3(9.3) 25.8(6.6) 46.0(5.6) 
MBP 99.7(10.3) 91.1(11.6) 90.7(11.8) 97.9(9.8) 
 
Table 3. Changes in MAP, systolic, and diastolic blood pressure during LBNP. 
Over the course of the lower body negative pressure protocol, the heart rate (mean 
± SD) increased 62.0% from 66.4 ± 12.4 beats/min at baseline to 107.6 ± 29.2 
beats/min at the symptomatic phase, and decreased to 57.81 ± 9.0 beats/min 
during recovery (p < 0.05 for recovery vs. baseline and for recovery vs. 
symptomatic (Figure 9)). 
 
 
Figure 9. Mean Heart rate increased by substantially over the course of the LBNP protocol and 
decreased to sub baseline levels during the recovery period. 
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Figure 10 summarizes the changes in HR and systolic BP. 
 
 
Figure 10. The classically described and expected observation, hypotension and tachycardia, were 




Finger PPG amplitude (height) decreased in all subjects during progressive lower 
body negative pressure challenge. Overall, the finger PPG amplitude decreased by 
34.6 ± 17.6% (p = 0.009; Fig 11) between baseline and the highest tolerated 
LBNP. In contrast, forehead amplitude changed by only 2.4 ± 16.0% (p=NS; Fig 
12). The intra-subject differential response between changes in finger and 




Figure 11. Overall, the finger PPG amplitude decreased by 34.6 from the start of the study to the 
highest level of tolerated lower body negative pressure. 
 
Figure 12. There was overall no change in the forehead PPG amplitude between the start of the 







Over the course of a 40-minute progressive LBNP challenge, the average decrease 
in MAP was only 7.4 mmHg. There nonetheless were declines in forehead and 
finger PPG width of 48.4% and 32.7%, respectively. Linear regression analysis of 
the forehead and finger plethysmographic waveform widths generated slopes of -
1.113 (R = -0.727, Fig. 13) and -0.591 (R = -0.666, Fig. 14), respectively. Linear 
regression of forehead is included in Figure 14 for comparison (dashed line). 
Forehead width was also significantly greater than that of the finger at baseline, 
210.4ms compared to 163.2ms. However, by the end of the study, both widths had 
converged to similar durations ~120ms. 
 
 
Figure 13. There was a steady decrease in forehead PPG width. Linear regression analysis 





Figure 14. Linear regression analysis of forehead (dashed line) and finger (solid line) PPG. The 




Amplitude density increased in the respiratory frequency band of the PPG 
waveform during the progressive hypovolemic challenge. Overall, the respiratory 
modulation of the ear PPG increased  (p=0.021, Wilcoxon) from baseline to the 
symptomatic phase (150%) as measured within the respiratory frequency band 
(0.19-0.3) (Figure 15). 
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Figure 15.  Displays the overall trend in amplitude density for the ear PPG at both the respiratory 
and autonomic frequency bands.  
 
With the application of progressively greater levels of negative pressure, the ear 
PPG waveform was modulated in part by the autonomic nervous system, in 
addition to the respiratory system. A representative example of this phenomenon 
can be seen in Figure 16, which shows respiration occurring at a rate of 0.4Hz, 
where as the PPG is oscillating at 0.17 Hz, a known parasympathetic frequency. 
Within the ear PPG autonomic frequency (0.12-0.18) there was first an increase 
(87%), during the early stages of LBNP, followed by a decrease (return to 




Figure 16.  This tracing was taken at -70mmHg, during the transition from PRESYMP to SYMP. 
The ear PPG waveform (bottom) was modulated in part by the autonomic nervous system, and not 
by the respiratory system (top). A laser Doppler flowmeter tracing is shown for comparison also 
oscillating at the parasympathetic frequency (middle).   
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The finger PPG demonstrated less than a 10% fluctuation at either frequency 
during the LBNP runs (p=NS). 
 
LASER DOPPLER FLOWMETRY  
 
During the period when subjects experienced symptoms of hypovolemic shock, 
finger flow decreased by 52.2 +/- 12.3% between BASE and PRESYMPT (Figure 
17) (p 0.01). In contrast, forehead flow remained within 9.5 +/- 53.1% of BASE 
(Figure 12); resulting in skin blood flow differences between the forehead and 
finger (p = 0.03). The maintenance of forehead flow was associated with 
oscillatory activity consistent with a parasympathetic frequency band (0.12 – 0.20 
Hz, Figure 16. At SYMPT, finger flow decreased by 57.4 +/- 19.8% (p = 0.048) 
and forehead flow decreased by 37.2 +/-14.0% (p = 0.048) from PRESYMPT. 
Both sites increased promptly upon release of LBNP.   
 
 
Figure 17. Finger blood flow shown to progressively and steadily decrease during LBNP as 




Figure 18. Forehead blood flow shown to be maintained within approximately 10% of baseline 





















The most intriguing and exciting finding in our study was the relative sparing of 
central cutaneous blood flow when compared to a peripheral site. This was 
indicated by observable and quantifiable changes in the PPG waveform 
amplitude, width, and autonomic induced oscillations. To our knowledge, we are 
the first group to report such autonomic modulations in the PPG waveform, and 
thus to document these changes at the level of the terminal arterioles.     
 
Our study sought to determine the effectiveness of the PPG waveform as a tool to 
distinguish regional differences in regulation of the microvasculature in the 
setting of the removal of between 1.5 and 2 liters of blood, via LBNP simulated 
hypovolemia, in healthy volunteers. This analysis focused on changes in PPG 
amplitude and width between the microvasculature of the finger, a surrogate for 
peripheral effects, and the forehead and ear, surrogates for central effects.   Our 
aim was to provide greater insight into the interplay between the respiratory, local 
microvascular, and autonomic nervous system in the differing regulation of 
central and peripheral microvascular blood flow. This is important, as monitoring 
from central sites may be indicative of underlying circulatory effects at critical 
locations such as the brain. Additional analysis was sought to quantify the 
respiratory system’s effect on the PPG waveform with the intention that this 
might serve as a sensitive monitor of volume status. 
 
In order to appreciate the results and implications of this study, it is necessary to 
discuss what was observed, consider the relevance of the results, set forth 
possible explanations for the data, detail the limitations of the study, and suggest 





VITAL SIGN CHANGES 
 
The observed changes in vital signs, hypotension and tachycardia, were consistent 
with the well-established clinical model of hypovolemic shock. The American 
College of Surgeons Committee on Trauma defines four stages of shock: Loss of 
up to 15% of the circulating volume (750 mL) may produce little in terms of 
obvious symptoms, while loss of up to 30% of the circulating volume (1.5 L) may 
result in mild tachycardia, tachypnea, and anxiety. Hypotension, marked 
tachycardia [i.e., pulse >110 to 120 beats per minute (bpm)], and confusion may 
not be evident until more than 30% of the blood volume has been lost; loss of 
40% of circulating volume (2 L) is immediately life threatening, and generally 
requires operative control of bleeding.80  
 
Using the fundamental equation of cardiovascular physiology, MAP = CO (HR x 
SV) x SVR, a decrease in circulating volume causes MAP to fall. This results in a 
compensatory increase in both CO and SVR in attempt to maintain organ 
perfusion. In our study blood pressure was well preserved, showing a less than 
10% decrease from baseline, until the final moments of the study, at which time 
reperfusion was initiated. This reperfusion was accompanied by a decrease in 
pulse pressure, manifested as a decrease in systolic blood pressure and an increase 
in diastolic blood pressure, which is representative of compensatory sympathetic 
activation and resultant elevations in vascular tone. Additionally, there was 
continuous and increasing baroreceptors activation, causing a steady increase in 
heart rate.  
 
Our results with regard to vital sign changes demonstrate that we were able to 
take our subjects to a significant level of hypovolemia. This validates our 
experimental model and gives us a way to standardize the estimated blood 






As expected, the finger PPG amplitude tracing declined over the course of the 
progressive LBNP challenge.  This challenge is associated with a pronounced 
decrease in stroke volume and compensatory upper extremity vasoconstriction77. 
It is the increase in sympathetic tone, with its resulting vasoconstriction, which 
causes a decrease in microvascular compliance and distensability.  Thus with each 
systole there is smaller overall volume of blood pumped into the 
microvasculature, the percentage of absorbed light emitted by the pulse oximeter 
decreases, and the amplitude voltage is lessened. 
 
A less pronounced response in the forehead PPG tracing likewise was consistent 
with our hypothesis that this region of the body would be protected during 
hypovolemia, in view of its previously documented protection from systemic 
vasoconstrictive challenges8, 23. However, the maintenance of forehead PPG 
amplitude in the presence of a decline in stroke volume suggests activation of 
added means to preserve blood flow to this region. The potential for two such 
processes -- local vasodilatation that may be attributable to recently documented 
cholinergic vasodilator mechanisms78 and/or shunting from constricted regions in 
the periphery remain to be explored. The later mechanism is currently being 




Our data show that overall PPG width decreases in the context of LBNP, 
regardless of monitoring site.  There was a more rapid decrease in the 
plethysmographic width of the forehead than of the finger during progressive 
hypovolemia. Additionally, the overall decrease in forehead width was also 
greater than that of the finger. Both width durations concluded at approximately 
120ms, despite the forehead starting at 210.4ms and the finger starting at 
163.2ms. The decline in width and the difference between the forehead and finger 
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responses were noted despite only a slight change (7.4%) in mean BP, suggesting 
that there was a greater decrease in relative intravascular volume than suggested 
by blood pressure.  
 
Looking at the contribution of hypovolemia and vasoconstriction in isolation 
would suggest that hypovolemia should decrease the time during which a pulse of 
blood is detected by a sensor. If vessel caliber is constant, the width of a given 
waveform should decrease in proportion to the decline in stroke volume. The 
effect of hypovolemia is seen in or our result as a decrease in PPG width in both 
the finger and the forehead. The accompanying reflexive tachycardia seen with 
LBNP also serves to decrease stroke volume. Hence there would be less pulsatile 
flow with each cardiac cycle to the vasculature, and therefore a decreased width.  
 
Vasoconstriction, as seen in the finger, reduces vessel diameter. In addition, 
vasoconstriction also reduces vessel compliance. Hence, with vasoconstriction, 
one would observe a decrease in the volume of blood that moves through the 
vessel in a given time. This becomes confusing, however, because the actual 
velocity of the blood likely increases in the context of vasoconstriction as 
predicted by the continuity equation.  Additionally, with vasoconstriction there is 
potential for volume redistribution to more compliant parallel vascular beds. 
Overall then, the effect of vasoconstriction on the PPG width is difficult to 
predict.   
 
In this context, the differing response of the finger and forehead widths becomes 
difficult to explain. In a region such as the forehead, which is known to be 
relatively immune to adrenergic influence, the width serves as a much more pure 
measurement, as drastic changes in vessel diameter are not occurring. Finger PPG 
width measurement, however, is much less useful as there are simply too many 
variables which confound the measurement. It seems most logical to assume that 
width may best serve as an indicator of forward flow (SV/ CO) rather than vessel 
compliance or caliber. 
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RESPIRATORY MODULATION ANALYSIS 
 
Though there was an overall increase in the amplitude density at the respiratory 
frequency (0.2Hz) from baseline to the onset of symptoms, it was not the 
expected constant and steady increase at every negative pressure interval.  
Specifically, at -30 there was a decrease compared to baseline, from 2.5 x10-4 
V/Hz2to 2.1 x 10-4 V/Hz2.  Additionally, though the overall trend was an increase 
in amplitude density at the respiratory frequency, this was not necessarily 
representative of individual subjects.  Some subjects had greater levels of 
oscillations at baseline than others, and some showed more pronounced decreases 
in amplitude density upon application of negative pressure compared to baseline. 
 
Based on the proposed mechanism for respiratory induced oscillations, this 
situation creates discordance.  The reasoning behind respiratory induced 
oscillations of the PPG is that each breath sequesters a volume of blood, assumed 
to be approximately one quarter to one half a liter, in the pulmonary vasculature.  
Thus each inspiration represents a small hypovolemic challenge, and when 
superimposed on a large hypovolemic challenge, such as hemorrhage or LBNP, 
there should be a decrease in systolic pressure (an exaggeration of physiologic 
pulsus paradoxus) as well as a noticeable and quantifiable dip in both the AC and 
DC components of the PPG waveform.  Since each negative pressure interval 
represents a greater degree of hypovolemia, it stands to reason that there should 
be a steady increase in respiratory induced oscillations, as measured by spectral 
domain analysis and amplitude density, at each pressure interval in our protocol.   
 
A possible explanation for these results may lie in the newfound autonomic 
modulation of the ear PPG. To our knowledge, this is the first time that this 
phenomenon has been described. This modulation occurs at a frequency very 
close to the respiratory frequency, and the oscillations observed are thus likely not 
solely the result of respirations, but also the effect of the parasympathetic nervous 
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systems on the underlying microvasculature. We can then immediately conclude 
that the occurrence of autonomic modulation needs to be considered when 
studying signals that have their origins from central sites (ear). Additionally, the 
use of the PPG to monitor autonomic balance is intriguing and needs further 
investigation. 
 
As a corollary, the same parasympathetic modulation was seen in the laser 
Doppler tracings, and is a well-documented effect in the setting of laser Doppler 
flowmetry. It is highly likely, then, that we were observing the same 
parasympathetic induced oscillations of the vasculature moving proximally up the 
microcirculation to the level of the terminal arterioles (the level measured by the 
PPG). 
 
SPARING OF THE CENTRAL MICROVASCULATURE: AN EXPLANATION 
 
Though this thesis has examined each component of the PPG waveform 
individually for analysis and discussion, it is paramount to remember that these 
changes happen in conjunction with one another.  To truly begin to understand the 
underlying physiological processes occurring in the microcirculation during 
hypovolemia, we must look at the entirety of the PPG data. Our data have 
revealed the following: hypovolemia with lower body negative pressure induced 
virtually no change in the amplitude of the forehead PPG tracing despite causing a 
significant decline in the finger PPG amplitude; hypovolemia induces a greater 
decline in the width of the PPG tracing in the forehead than in the finger; the 
occurrence of autonomic modulation in the ear but not finer PPG waveform needs 
to be taken into account when studying signals that have their origins from central 
sites (e.g. ear & forehead); forehead flow as measured by laser Doppler flowmetry 
was maintained during LBNP until subjects became symptomatic, whereas finger 
flow progressively declines throughout. We speculate that these findings are due 




Almost all blood vessels have stretch receptors. These receptors are most 
prominent at the carotid sinus, but are also apparent throughout the body. The 
development of autonomic oscillations in the PPG tracing could be due to 
activation of such receptors when there is significant systemic hypoperfusion. A 
marked hypovolemic state, as would be induced by severe blood loss or 
pronounced LBNP, decreases preload and likewise decreases stroke volume. At 
moderate degrees of hypovolemia, the parasympathetic compensatory response is 
probably limited to the microcirculation, with graded vasodilation and regional 
redistribution of blood. In more severe hypovolemia, major vessels may dilate, 
and there is preservation at the central microvascular level. 
 
The proposed cholinergic mediated mechanism for terminal arteriolar and 
microvascular flow preservation is also supported by our laser Doppler flowmetry 
findings. A laser Doppler probe placed on the forehead adjacent to the PPG probe 
demonstrated oscillatory activity consistent with parasympathetic modulations of 
the microvasculature. It is worth noting that the laser Doppler measures flow 
distal to the PPG, at the level of the precapillaries and capillaries. The 
combination of preserved flow, as indicated by both a maintained forehead PPG 
amplitude and forehead laser Doppler flowmeters, and increased oscillations in the 
context of systemic vasoconstriction is consistent with microvascular oscillatory 
activity contributing to the discordance between large cerebral arterial blood flow 
changes and preservation of CNS blood flow.  
  
The term cholinergic oscillatory control of the microvasculature (COCmicvasc) 
was coined by one of our members (DGS)34 as a response of the body to optimize 
delivery of blood flow to the microvasculature in the context of decreased flow 
proximal to the precapillary sphincter. It also might serve to offset capillary 
congestion. In the context of hypoperfusion, the microvasculature of certain 
portions of the body (e.g., brain, forehead) develops what may be referred to as 
rhythmic inhibition of precapillary sphincters such that capillaries dilate in 
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synchrony and thereby provide transient decreases in local resistance (in 
proportion to the fourth power of the radius). This enables them to “do more with 
less”. 
 
Logically, the oscillations at the level of the microvasculature maintain 
autoregulation in the context of a manageable compromise of perfusion. The 
larger response that involves the plethysmograph is one where the body senses 
that, regardless of how efficiently blood is used when it gets to an area of the 
brain, there is not an adequate blood supply. Therefore the conduits going to the 
brain dilate to facilitate delivery to this region. 
 
Vascular smooth muscle cells typically oscillate out-of-phase and thus may offset 
one another in the absence of extrinsic (e.g., neural) control. When a controlling 
force such as COCmicvasc is activated, it synchronizes the oscillations of 
capillaries of the same branching order81 and thereby increases the summated 
amplitude of the oscillations under the laser Doppler probe. The resistance 
(impedance) of a vessel (or vascular bed) whose diameter varies sinusoidally is 
lower than that of a constant-caliber vessel with the same average diameter82.  
 
Further, if one views the microcirculation as a form of parallel circuitry, then, 
since the total resistance of a parallel circuit is less than that of any of its 
branches, the enhanced oscillations of the arteriolar– capillary networks would 
lower the circuit’s resistance. The potential physiological impact of COCmicvasc 
is suggested by the evidence that oscillations of neighboring terminal vessels 
become synchronized during clamping of a regional feeding artery83 and by the 
development of 0.13-Hz oscillations in laser Doppler flux in the rat cerebral 
cortex during norepinephrine infusion and hypoperfusion84. However, in neither 







Our study was subject to several limitations, which are worth mentioning, as they 
should be taken into account when interpreting our results.  They also serve as 
points to address in any future experiments.  
 
We had a relatively small number of subjects, hence our statistical analysis was 
not as strong as we would have liked, even though, prior power analysis indicated 
that six subjects would be required to detect a 50% intra-subject change in 
respiratory induced oscillations of the plethysmographic signal, with an alpha of 
0.05 and a power of 0.9038. Another limiting factor of our study is the study 
population. These subjects were all young healthy individuals, and are not 
representative of the population as a whole. However, in trying to characterize 
these novel observable phenomena, healthy subjects are likely the best candidates 
to do so with.  
 
Our use of spectral analysis to analyze the waveform from the entire case in the 
present study has the advantage being relatively immune to isolated artifacts such 
as motion.38 It, therefore, was preferable for the overall assessment of the impact 
of ventilation on the plethysmographic signals. However, the integrated 
assessment of such long study intervals is not preferred for analysis of short-term 
events. In the final moments of the study, when subjects transition from a period 
of compensated to decompensated shock, there may be events that occur on such 
a timescale as to be missed by simple spectral domain analysis.  For events 
happening on such a short time scale, wavelet analysis such as the Hilbert-Huang 
transform (HHT) are being looked into as alternative means of investigation. HHT 
looks to be the state-of-the-art method of energy-time-frequency representation of 
non-stationary and nonlinear signals, This signal processing technique allows 
greater resolution in both the time and frequency domain. 
 
It is paramount to consistently quantify the characteristics of the PPG in such a 
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way as to allow the results from research efforts be translated into clinically 
useful devices.4 At this time, no calibration procedure is known to standardize the 
PPG amplitude for comparing one patient waveform to another. The signal is 
therefore not given a unit designation. Similar to central venous pressure 
measurement, the value of the plethysmograph comes from an analysis over time, 
as opposed to any absolute number.4 
 
The PPG width as a variable is a complex measurement, dependent upon heart 
rate, stroke volume, and also PPG amplitude. A decrease in stroke volume 
whether due to hypovolemia or an increase in heart rate will cause the width to 
decrease regardless of what is happening to vessel diameter. Also, as width is 
conventionally taken at the point of half the amplitude, as amplitude changes so 
does the point at which widths is measured. Thus width analysis is less robust 
than that of amplitude or respiratory/ autonomic induced oscillations, 
 
The concept that LBNP may be an effective model to study cardiovascular 
responses to acute hemorrhage in humans is tenable from several perspectives. 
However, it should be emphasized that application of LBNP does not mimic all of 
the responses observed in traumatic hemorrhage, as LBNP clearly does not induce 
tissue trauma or subsequent metabolic responses (e.g., acidosis). Rather, data 
suggest that LBNP may be used as a model to study acute hemodynamic 
responses to the central hypovolemia associated with hemorrhage.77  
 
Further, at a given level of negative pressure, each individual had a different 
amount of blood sequestered in his or her lower body. This makes data analysis 
difficult when attempting to compare responses at a particular level of negative 
pressure.  Subjects can be compared at endpoints, as was done in our study, or 
indirectly with measures such as changes in vital signs.  
 
Finally, enthusiasm for the method of assessment of PPG respiratory induced 
oscillations tested herein should be tempered by the realization that there is wide 
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inter-subject variability in baseline autonomic balance and thus in the degree of 
existing oscillations. This challenge will have to be overcome if the PPG is to be 




We were able to demonstrate comparable preservation of flow in the forehead 
during lower body negative pressure, indicated by both PPG and laser Doppler 
data. It follows that we should determine if these changes are in any way 
reflective of what is occurring in a major vessel of the brain. A corollary study, 
which is presently being undertaken, involves transcranial Doppler measurements 
of the middle cerebral artery (MCA) flow in the context of lower body negative 
pressure.  From the standpoint of cerebral autoregulation, we would expect that 
MCA flow falls progressively with LBNP and that maintenance is mostly at 
microvasculature.  
 
Potential for further studies utilizing transcranial Doppler include a low-dose 
intravenous phenylephrine and/or hyperventilation to induce cerebral 
vasoconstriction and again comparing responses of the micro and macro 
vasculature. There also exist potential for measuring parenchymal blood flow and 
comparing that with blood flow in both the cutaneous microvasculature and/or 
MCA. Currently, members of our team are working to make laser Doppler 
embedded grids and strips to study epilepsy patients who are undergoing cortical 
resection for intractable seizure activity.  
 
Two further areas that could be studied in attempt to help define the underlying 
physiology behind the observed effects on the PPG waveform during progressive 
hypovolemia are use of echocardiography to see if oscillations also occurring in 
stroke volume and eutectic mixture of local anesthetic (EMLA) under 
plethysmography, to investigate whether our observed oscillations are prevented 
by local anesthetic (equal quantities, by weight, of lidocaine and prilocaine), which 
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would support their autonomic nature. Members of our group are currently 




In summary we saw that during a hypovolemic challenge in healthy volunteers, 
despite minimal changes in blood pressure, appreciable changes in PPG 
amplitude, width, and respiratory induced oscillations could be detected and 
quantified. These changes differed based on the region being studied, and offer 
insight into contrasting regulation of central and peripheral terminal arteriolar and 
microvascular blood flow. The most intriguing and exciting finding is the relative 
sparing of central cutaneous blood flow when compared to a peripheral site as 
indicated by observable and quantifiable changes in the PPG waveform 
amplitude, width, and autonomic induced oscillations. At this stage our goal is 
still to elucidate the underlying physiology reflected in the PPG waveforms as 
opposed to guiding therapy. We hope that ultimately these noninvasively derived 
PPG parameters will give clinicians useful information about central cardiac 
function and its interplay with the respiratory and autonomic nervous systems and 
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